In 2018, the FDA granted approval to cannabidiol (CBD; Epidiolex) for the treatment of rare forms of epilepsy, Dravet syndrome and Lennox-Gastaut syndrome, …

Leave a Reply

Your email address will not be published. Required fields are marked *